Rare diseases
Investigational molecules
Locations
323 Allerton Avenue, 94080-4816, United States
Clinical research in metastatic and unresectable recurrent HNSCC focuses on immunotherapy-based combinations and first-line treatment settings for advanced disease.
The sponsor’s work in this area centers on treatment options for patients with advanced disease who have not yet received therapy for their metastatic or recurrent cancer.
Alx Oncology Holdings Inc. runs clinical trials in conditions such as Neoplasm malignant, Squamous cell carcinoma of head and neck, Squamous cell carcinoma, Head and neck cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
France
BelgiumBelgiumBelgium
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
